catalym
The role leads the strategic direction for Clinical Drug Safety, overseeing safety profile evaluation throughout product lifecycles and shaping safety standards to support clinical development programs. It involves providing medical expertise for safety surveillance, signal detection, regulatory reporting, and risk management across global trials.
CatalYm is a biotechnology company pioneering the neutralization of GDF-15, a key immune resistance mechanism in cancer, to restore anti-tumor immune activity and improve responses to checkpoint inhibition. The company is developing visugromab, an immune therapy targeting solid tumors and cancer cachexia, currently advancing into Phase 2/3 clinical development. Led by an international team of experienced drug developers, CatalYm is headquartered in Planegg-Martinsried, Germany.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for catalym.
catalym didn’t post a salary, so this is our estimate from similar listings.
27% below the average for this role
Senior Medical Scientist, Drug Safety
Arrowhead Pharmaceuticals
Director, Drug Safety Physician
Jobgether
Director Drug Safety & Pharmacovigilance Medical Safety
Acadia Pharmaceuticals Inc.
Associate Director, Pharmacovigilance Scientist
Tango Therapeutics
Pharmacovigilance Physician
Venesco
Medical Safety Specialist
Sandoz